|
PRIMIS celebrated its 20th anniversary in 2020, the same year that School of Medicine at the University of Nottingham celebrated its 50th anniversary. We are extremely proud of our long and thriving relationship.
The COVID-19 pandemic posed unprecedented challenges to healthcare systems worldwide, but it also spurred significant innovations and improvements in healthcare quality, patient safety, and the sharing of patient information.
As part of our work with the UKHSA on vaccination uptake, PRIMIS produced a data specification for the COVID-19 vaccination and supported its implementation by GP IT system suppliers. The specification includes attributes necessary for tracking and monitoring vaccination efforts and remains the only specification approved for reporting as well as call and recall purposes.
Prior to the COVID-19 pandemic, PRIMIS experts had worked with the University of Liverpool on influenza preparedness, including the development of tooling to support GP practices in the event of a surge. During the COVID-19 pandemic, PRIMIS collaborated with EMIS Health on the deployment of the tooling, which helped GP practices to triage and manage hundreds of thousands of patients correctly, as well as generate consistent and standardised data on patients presenting to general practice with COVID-19.
PRIMIS continued to support the national roll out of PINCER during the pandemic. In 2023 investigative work in collaboration with the Bennett Institute for Applied Data Science, published in BMJ Medicine , looked at the impact of the COVID-19 pandemic on safe prescribing using the PINCER indicators as a marker. The study, based on 57 million primary care records, demonstrated that hazardous prescribing had been largely unaffected during the pandemic.
The impact of the PINCER intervention extends across multiple dimensions including patient outcomes, healthcare practices, policy development, and economic savings. The PRIMIS team led on the development of the 4* REF 2021 impact case study, which recognises the changes and benefits that research has had on society, economy, public policy and practice, environment, and quality of life.
Throughout our long history, we have demonstrated our expertise in supporting the widespread scale and adoption of innovations, and our ability to bridge the gap between research discoveries and their application in clinical or real-world settings. FAMCAT2 is another such example. The algorithm helps to identify patients with familial hypercholesterolemia (FH); early detection and effective management of FH are crucial for reducing the risk of cardiovascular complications and improving long-term outcomes for affected individuals and their families. We had previously worked with academics at the University of Nottingham to help validate earlier iterations of the algorithm and were delighted to support its further scale and spread, which included translating the algorithm into a workable data model for use in primary care settings. PRIMIS continues to build partnerships to promote the use of the algorithm within population health management systems, and in 2023, registered FAMCAT2 as a medical device.
PRIMIS continues to work with the NHS, industry, academia and charities to identify and act on opportunities to make bigger and better data-driven healthcare improvements.
Back to the main PRIMIS History
|